Clinical trial
Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired…
NCT00301392 · Tokyo University, Other · Completed
Key facts
| NCT number | NCT00301392 |
|---|---|
| Title | Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT) |
| Official title | Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT) |
| Lead sponsor | Tokyo University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Glucose Intolerance |
| Intervention type | Drug, Other |
| Interventions | life-style intervention, Life style interventions plus concomitant use of pitavastatin. |
| Enrollment | 1,240 |
| Start date | Apr 1, 2006 |
| Primary completion | Mar 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Mar 10, 2006 |
| Last update posted | Sep 6, 2013 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: